Role of Phase II Enzymes in the Bioactivation of 1,4-Dichlorobenzene and 1,4-Dibromobenzene

Abstract

The use of sodium phenobarbital (PB, CYP2B1 inducer) combined with β-naphthoflavone (β-NF, 1A1) to induce certain Phase I reactions in S9 liver fractions is a standard method for conducting short-term bioassays for genotoxicity. However, because post-oxidative enzymes are also able to activate many precarcinogens, we tested the possibility of adapting S9 liver fractions derived from Phase II-induced rodents to the field of genetic toxicology. In this study, S9 liver fractions derived from Swiss albino CD1 mice fed 7.5g/kg 2-(3)-tert-butyl-4-hydroxyanisole (BHA; a monofunctional Phase II-inducer) for 3 weeks, show a clear pattern of induction with an approximately 3.5–9.5-fold increase in glutathione S-transferase activity. In vitro DNA binding of the promutagenic agents, [¹⁴C]-l,4-dichlorobenzene (DCB) and [¹⁴C]-1,4-dibromobenzene (DBB), is mediated by such metabolic liver preparations and showed a significant increase in covalent binding capability. In some instances, enzyme activity was more elevated when compared to that obtained with traditional (Phase I-induced) S9. Together with DNA binding, the genetic response of these chemicals in the diploid D₇ strain of Saccharomyces cerevisiae used as a biological test system, revealed the ability of the BHA-derived preparations to activate the promutagenic agents, as exemplified by the significant enhancement of mitotic gene-conversion (up to 5.2-fold for DCB and 3.4-fold for DBB) and reverse point mutation (up to 3.6-fold for DCB and 2.5-fold for DBB) at a 4mM concentration. This novel metabolising biosystem, with enhanced Phase II activity, is recommended together with a traditional S9, for detecting unknown promutagens in genotoxicity studies. The routine use of either oxidative or post-oxidative S9 increases the responsiveness of the test and can contribute to the identification of promutagens not detected when using traditional protocols.

Keywords

monooxygenase glutathione S-transferase enzyme induction 1,4-dichlorobenzene 1,4-dibromobenzene

Get full access to this article

View all access options for this article.

References

Lave

B.L.

, Ennever

F.K.

, Rosenkranz

H.S.

, and Omenn

G.S.

(1988). Information value of the rodent bioassays. Nature, London 336, 631–633.

Lave

B.L.

, and Omenn

G.S.

(1988). Cost-effectiveness of short-term tests for carcinogenicity. Nature, London 324, 29–34.

Wolf

C.R.

, Berry

P.N.

, Nash

J.A.

, Green

, and Lock

E.A.

(1984). Role of microsomal and cytosolic glutathione S-transferase in conjugation of hexachlor-1: 3-butadiene and its possible relevance to toxicity. Journal of Pharmacology and Experimental Therapeutics 228, 202–208.

Kasper

C.B.

, and Henton

(1980). Glucuronidation. In Enzymatic Basis of Detoxification (ed. Jacoby

W.B.

), pp. 3–12. New York: Academic Press.

Runge-Morris

, and Wilusz

(1994). Suppression of hydroxysteroid sulfotransferase-a gene expression by 3-methylcholanthrene. Toxicology and Applied Pharmacology 125, 133–141.

Hanna

P.E.

, Banks

R.B.

, and Marhevka

V.P.

(1992). Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acetyltransferase: a selective probe of N-acetyltransferase multiplicity. Molecular Pharmacology 21, 159–168.

Guengerich

F.P.

(1985). Enzymatic activation of chemicals to toxic metabolites. CRC Critical Review of Toxicology 14, 259–307.

Benson

A.M.

, Batzinger

R.P.

, Om

S.Y.G.

, Bueding

, Cha

Y-N.

, & Talalay

(1978). Elevation of glutathione S-transferase activities and protection against mutagenic metabolites of benzo[a]pyrene by dietary antioxidants. Cancer Research 38, 4484–4493.

Paolini

, Barone

, Corsi

, Paganin

, and Revoltella

R.P.

(1991). Expression and inducibility of drug metabolizing enzymes in novel murine liver epithelial cell lines and their ability to activate precarcinogens. Cancer Research 51, 301–309.

10.

Omura

, and Sato

(1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidences for its hemoprotein nature. Journal of Biological Chemistry 239, 2370–2378.

11.

Bruce

(1967). Microsomal NADPH cytochrome c-reductase. Methods in Enzymology 10, 551–553.

12.

Mazel

(1971). Experiments illustrating drug metabolism in vitro. In Fundamentals of Drug Metabolism and Drug Disposition (ed. La Du

B.N.

, Mandel

L.M.

, Way

E.L.

), pp. 546–550. Baltimore, MD, USA: William & Wilkins.

13.

Nash

(1953). Colorimetric estimation of formaldehyde by means of Hantzsch reaction. Biochemical Journal 55, 416–421.

14.

Aitio

(1978). A simple and sensitive assay of 7-ethoxycoumarin deethylation. Analytical Biochemistry 85, 448.

15.

Habig

W.H.

, Pabst

M.J.

, and Jakoby

W.B.

(1974). Glutathione S-transferase: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 249, 7130–7139.

16.

Grilli

, Arfellini

, Colacci

, Mazzullo

, and Prodi

(1985). In vivo and in vitro covalent binding of chlorobenzene to nucleic acids. Gann 76, 745–751.

17.

Zimmermann

F.K.

, Kern

, and Rosenberg

H.S.

(1975). A yeast strain for simultaneous detection of induced mitotic crossing-over, mitotic gene conversion and reverse mutation. Mutation Research 28, 381–388.

18.

Lowry

O.H.

, Rosenbrough

H.J.

, Farr

A.L.

, and Randall

R.J.

(1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265–275.

19.

Bailey

Y.L.

(1967). Techniques in Protein Chemistry, pp. 340–341. Amsterdam: Elseiver.

20.

Box

G.E.P.

, and Hunter

W.G.

(1978). Statistics for Experiments, pp. 80–82. New York: Wiley.

21.

Cha

Y-N.

, Martz

, and Bueding

(1978). Enhancement of liver microsome epoxide hydrolase activity in rodents by treatment with 3(3)-tert-butyl-4-hydroxyanisole. Cancer Research 38, 4496–4498.

22.

Paolini

, Mesirca

, Pozzetti

, Silingardi

, Grilli

, & Cantelli-Forti

(1992). Strategies for advancement of short-term mutagenicity tests: on the optimal ionic strength for the liver microsomal assay. Carcinogenesis 13, 1403–1408.